Last Updated: May 11, 2026

List of Excipients in API albuterol


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing albuterol

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Merck Sharp & Dohme Corp. PROVENTIL HFA albuterol sulfate 0085-1132 ALCOHOL
Merck Sharp & Dohme Corp. PROVENTIL HFA albuterol sulfate 0085-1132 NORFLURANE
Merck Sharp & Dohme Corp. PROVENTIL HFA albuterol sulfate 0085-1132 OLEIC ACID
Teva Pharmaceuticals USA Inc ALBUTEROL SULFATE albuterol sulfate 0093-3174 ALCOHOL
Teva Pharmaceuticals USA Inc ALBUTEROL SULFATE albuterol sulfate 0093-3174 NORFLURANE
GlaxoSmithKline LLC VENTOLIN albuterol sulfate 0173-0682 NORFLURANE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Start Trial

Excipients in ANDA-approved (generic) drugs containing albuterol

Company Ingredient NDC Excipient
Rebel Distributors Corp albuterol 21695-198 DICHLOROFLUOROMETHANE
Rebel Distributors Corp albuterol 21695-198 OLEIC ACID
Rebel Distributors Corp albuterol 21695-198 TRICHLOROMONOFLUOROMETHANE
Mylan Institutional Inc albuterol 51079-657 LACTOSE MONOHYDRATE
Mylan Institutional Inc albuterol 51079-657 MAGNESIUM STEARATE
Mylan Institutional Inc albuterol 51079-657 SODIUM LAURYL SULFATE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Start Trial

Detailed excipient profiles for albuterol

Excipient focus: 1,1,1,2-TETRACHLORO-2-FLUOROETHANE

Excipient focus: 1,1,1,2-TETRAFLUOROCHLOROETHANE

Excipient focus: 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE

Excipient focus: ALCOHOL

Excipient focus: ANHYDROUS CITRIC ACID

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: BENZALKONIUM CHLORIDE

Excipient focus: CALCIUM CHLORIDE

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: DEHYDRATED ALCOHOL

Excipient focus: DICHLOROFLUOROMETHANE

Excipient focus: EDETATE DISODIUM

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: HYDROCHLORIC ACID

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: NORFLURANE

Excipient focus: OLEIC ACID

Excipient focus: ORANGE

Excipient focus: POLYDEXTROSE

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POVIDONE K30

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SACCHARIN

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM BENZOATE

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM CITRATE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: SORBITOL

Excipient focus: SORBITOL SOLUTION

Excipient focus: STARCH, CORN

Excipient focus: SULFURIC ACID

albuterol drug variants containing SULFURIC ACID

Company Ingredient NDC
Mylan Pharmaceuticals Inc albuterol sulfate 0378-6991
Mylan Pharmaceuticals Inc albuterol sulfate 0378-7057
Mylan Pharmaceuticals Inc albuterol sulfate 0378-8270
Nephron Pharmaceuticals Corporation albuterol sulfate 0487-9501
Nephron Pharmaceuticals Corporation albuterol sulfate 0487-9901
Nephron Pharmaceuticals Corporation albuterol sulfate 0487-9904
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: TRICHLOROMONOFLUOROMETHANE

Excipient focus: TRISODIUM CITRATE DIHYDRATE

Excipient focus: WATER

Excipient focus: XANTHAN GUM

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links